Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE3.9700
- TODAY'S CHANGE (%)0.3700 (10.2778%)
- Bid / Lots3.8200/ 2
- Ask / Lots4.0000/ 10
- Open / Previous Close3.5800 / 3.6000
- Day Range
- 52 Week Range
- Volume1,294,108
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 8474 | 3.62 |
| 09:34 ET | 4800 | 3.615 |
| 09:36 ET | 4500 | 3.61 |
| 09:38 ET | 6858 | 3.62 |
| 09:39 ET | 800 | 3.62 |
| 09:41 ET | 1200 | 3.61 |
| 09:43 ET | 3452 | 3.6 |
| 09:45 ET | 1100 | 3.585 |
| 09:48 ET | 4816 | 3.585 |
| 09:50 ET | 802 | 3.61 |
| 09:52 ET | 1700 | 3.63 |
| 09:54 ET | 1977 | 3.63 |
| 09:56 ET | 1555 | 3.635 |
| 09:57 ET | 1850 | 3.63 |
| 09:59 ET | 1150 | 3.63 |
| 10:01 ET | 4700 | 3.625 |
| 10:03 ET | 2150 | 3.63 |
| 10:06 ET | 5107 | 3.615 |
| 10:08 ET | 2503 | 3.615 |
| 10:10 ET | 4976 | 3.615 |
| 10:12 ET | 1517 | 3.635 |
| 10:14 ET | 2882 | 3.625 |
| 10:15 ET | 2704 | 3.625 |
| 10:17 ET | 1750 | 3.625 |
| 10:19 ET | 2300 | 3.625 |
| 10:21 ET | 2790 | 3.635 |
| 10:24 ET | 1739 | 3.625 |
| 10:26 ET | 500 | 3.63 |
| 10:28 ET | 600 | 3.625 |
| 10:30 ET | 1211 | 3.64 |
| 10:32 ET | 1135 | 3.64 |
| 10:33 ET | 1300 | 3.645 |
| 10:35 ET | 200 | 3.65 |
| 10:37 ET | 734 | 3.66 |
| 10:39 ET | 960 | 3.665 |
| 10:42 ET | 3500 | 3.67 |
| 10:44 ET | 2199 | 3.665 |
| 10:46 ET | 1400 | 3.67 |
| 10:48 ET | 6686 | 3.655 |
| 10:50 ET | 300 | 3.655 |
| 10:51 ET | 2490 | 3.69 |
| 10:53 ET | 830 | 3.685 |
| 10:55 ET | 1188 | 3.695 |
| 10:57 ET | 1286 | 3.69 |
| 11:00 ET | 1027 | 3.67 |
| 11:02 ET | 1269 | 3.665 |
| 11:04 ET | 1212 | 3.685 |
| 11:06 ET | 400 | 3.685 |
| 11:08 ET | 200 | 3.685 |
| 11:09 ET | 2514 | 3.67 |
| 11:11 ET | 100 | 3.665 |
| 11:13 ET | 400 | 3.66 |
| 11:15 ET | 300 | 3.665 |
| 11:18 ET | 500 | 3.67 |
| 11:20 ET | 2357 | 3.685 |
| 11:22 ET | 419 | 3.69 |
| 11:24 ET | 500 | 3.685 |
| 11:26 ET | 677 | 3.67 |
| 11:27 ET | 11801 | 3.655 |
| 11:29 ET | 1700 | 3.655 |
| 11:31 ET | 1100 | 3.6563 |
| 11:33 ET | 8262 | 3.665 |
| 11:36 ET | 5200 | 3.685 |
| 11:38 ET | 1553 | 3.685 |
| 11:40 ET | 1500 | 3.69 |
| 11:42 ET | 2485 | 3.695 |
| 11:44 ET | 3343 | 3.695 |
| 11:45 ET | 766 | 3.695 |
| 11:47 ET | 24659 | 3.695 |
| 11:49 ET | 4502 | 3.7 |
| 11:51 ET | 3355 | 3.7 |
| 11:56 ET | 1741 | 3.715 |
| 11:58 ET | 730 | 3.71 |
| 12:00 ET | 200 | 3.71 |
| 12:02 ET | 4161 | 3.705 |
| 12:03 ET | 553 | 3.705 |
| 12:05 ET | 222 | 3.705 |
| 12:07 ET | 15527 | 3.7 |
| 12:09 ET | 5525 | 3.7 |
| 12:12 ET | 6870 | 3.7 |
| 12:14 ET | 489 | 3.7 |
| 12:16 ET | 652 | 3.7 |
| 12:18 ET | 4999 | 3.7 |
| 12:20 ET | 3201 | 3.7 |
| 12:21 ET | 1806 | 3.7 |
| 12:23 ET | 1996 | 3.7 |
| 12:25 ET | 4175 | 3.7 |
| 12:27 ET | 510 | 3.71 |
| 12:30 ET | 11368 | 3.715 |
| 12:32 ET | 1900 | 3.705 |
| 12:34 ET | 1199 | 3.7 |
| 12:36 ET | 1010 | 3.7 |
| 12:38 ET | 1801 | 3.7 |
| 12:39 ET | 600 | 3.7 |
| 12:41 ET | 2331 | 3.705 |
| 12:43 ET | 539 | 3.705 |
| 12:45 ET | 534 | 3.705 |
| 12:48 ET | 200 | 3.705 |
| 12:50 ET | 1500 | 3.715 |
| 12:52 ET | 2100 | 3.71 |
| 12:54 ET | 1949 | 3.705 |
| 12:56 ET | 100 | 3.705 |
| 12:57 ET | 800 | 3.71 |
| 12:59 ET | 659 | 3.715 |
| 01:01 ET | 300 | 3.715 |
| 01:03 ET | 822 | 3.715 |
| 01:06 ET | 1100 | 3.715 |
| 01:08 ET | 2135 | 3.725 |
| 01:10 ET | 5298 | 3.705 |
| 01:12 ET | 21237 | 3.73 |
| 01:14 ET | 2648 | 3.735 |
| 01:15 ET | 10568 | 3.755 |
| 01:17 ET | 2644 | 3.745 |
| 01:19 ET | 1590 | 3.755 |
| 01:21 ET | 1875 | 3.745 |
| 01:24 ET | 1842 | 3.745 |
| 01:26 ET | 344 | 3.745 |
| 01:28 ET | 4320 | 3.745 |
| 01:30 ET | 15093 | 3.745 |
| 01:32 ET | 1600 | 3.73 |
| 01:33 ET | 122 | 3.735 |
| 01:35 ET | 11765 | 3.765 |
| 01:37 ET | 2003 | 3.75 |
| 01:39 ET | 2577 | 3.745 |
| 01:42 ET | 3639 | 3.75 |
| 01:44 ET | 1826 | 3.745 |
| 01:46 ET | 2828 | 3.74 |
| 01:48 ET | 5962 | 3.755 |
| 01:50 ET | 2327 | 3.755 |
| 01:51 ET | 844 | 3.75 |
| 01:53 ET | 966 | 3.755 |
| 01:55 ET | 2890 | 3.755 |
| 01:57 ET | 761 | 3.755 |
| 02:00 ET | 30782 | 3.805 |
| 02:02 ET | 1100 | 3.805 |
| 02:04 ET | 7666 | 3.795 |
| 02:06 ET | 1316 | 3.785 |
| 02:08 ET | 690 | 3.785 |
| 02:09 ET | 1888 | 3.785 |
| 02:11 ET | 319 | 3.785 |
| 02:13 ET | 1436 | 3.795 |
| 02:15 ET | 700 | 3.785 |
| 02:18 ET | 200 | 3.785 |
| 02:20 ET | 800 | 3.795 |
| 02:22 ET | 200 | 3.795 |
| 02:24 ET | 900 | 3.8 |
| 02:26 ET | 5444 | 3.785 |
| 02:27 ET | 100 | 3.785 |
| 02:29 ET | 200 | 3.775 |
| 02:31 ET | 1470 | 3.775 |
| 02:33 ET | 222 | 3.775 |
| 02:36 ET | 568 | 3.775 |
| 02:38 ET | 100 | 3.775 |
| 02:40 ET | 300 | 3.775 |
| 02:42 ET | 100 | 3.775 |
| 02:44 ET | 45733 | 3.805 |
| 02:45 ET | 300 | 3.805 |
| 02:47 ET | 200 | 3.805 |
| 02:49 ET | 600 | 3.8 |
| 02:51 ET | 522 | 3.8 |
| 02:54 ET | 80628 | 3.835 |
| 02:56 ET | 2416 | 3.835 |
| 02:58 ET | 880 | 3.83 |
| 03:00 ET | 10843 | 3.865 |
| 03:02 ET | 3067 | 3.835 |
| 03:03 ET | 1271 | 3.845 |
| 03:05 ET | 1891 | 3.84 |
| 03:07 ET | 2534 | 3.85 |
| 03:09 ET | 8255 | 3.86 |
| 03:12 ET | 6464 | 3.88 |
| 03:14 ET | 14709 | 3.88 |
| 03:16 ET | 1685 | 3.865 |
| 03:18 ET | 575 | 3.865 |
| 03:20 ET | 2918 | 3.87 |
| 03:23 ET | 300 | 3.86 |
| 03:25 ET | 6792 | 3.89 |
| 03:27 ET | 9629 | 3.9 |
| 03:30 ET | 1284 | 3.9 |
| 03:32 ET | 46641 | 3.9 |
| 03:34 ET | 1816 | 3.905 |
| 03:36 ET | 1700 | 3.895 |
| 03:38 ET | 3102 | 3.885 |
| 03:39 ET | 1900 | 3.885 |
| 03:41 ET | 2841 | 3.89 |
| 03:43 ET | 1585 | 3.88 |
| 03:45 ET | 200 | 3.89 |
| 03:48 ET | 700 | 3.89 |
| 03:50 ET | 2473 | 3.885 |
| 03:52 ET | 15225 | 3.9 |
| 03:54 ET | 40003 | 3.955 |
| 03:56 ET | 53837 | 3.97 |
| 03:57 ET | 32687 | 3.955 |
| 03:59 ET | 282276 | 3.97 |
Sep 19, 2024
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer, from 7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
7:00AM ET on Thursday Sep 19, 2024 by Dow JonesPress Release: Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer, from 7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 957.9M | -3.4x | --- |
Cullinan Therapeutics Inc | 971.7M | -5.3x | --- |
Sana Biotechnology Inc | 943.3M | -3.8x | --- |
Mesoblast Ltd | 950.8M | -10.0x | --- |
Applied Therapeutics Inc | 963.6M | -5.5x | --- |
Phathom Pharmaceuticals Inc | 1.0B | -3.3x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $957.9M |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-1.16 |
Book Value | --- |
P/E Ratio | -3.4x |
Price/Sales (TTM) | 91.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,775.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
